The FDA granted De Novo authorization to Powerful Medical's Queen of Hearts, the first AI electrocardiogram model cleared specifically to identify acute myocardial infarction, including STEMI equivalents that standard interpretation frequently misses. Published data across more than 20 peer-reviewed studies and roughly 40,000 patients report approximately double the detection of true infarctions with up to fivefold fewer false positives. Because myocardial tissue loss is largely irreversible, earlier recognition at first medical contact preserves cardiac function that no later intervention can restore.
Key Points
- First FDA De Novo authorization for an AI ECG infarction model
- Detects roughly twice as many true heart attacks as standard reads
- Deployed at first contact: paramedics, emergency nurses, initial treating physicians
Longevity Analysis
Cardiac muscle does not meaningfully regenerate, so every minute of undetected arterial occlusion converts a survivable event into permanent loss of pumping capacity and a shortened functional lifespan. The advance here is interpretive rather than therapeutic: the same century-old 12-lead signal, read more accurately and earlier, at the ambulance and triage desk rather than after a cardiology handoff. Pattern recognition applied to data already being collected — the highest-yield form of optimization, because it removes diagnostic delay without adding a single new test, drug, or device to the patient.
Original published by Longevity.Technology, by Kyle Umipig.